Anti-tumor necrosis factor treatment in ankylosing spondylitis may not relate to poor prognosis in COVID-19
Arch Rheumatol
.
2020 Jun 25;36(1):142-143.
doi: 10.46497/ArchRheumatol.2021.8228.
eCollection 2021 Mar.
Authors
Nesrin Şen
1
,
Mehmet Engin Tezcan
1
Affiliation
1
Department of Rheumatology, University of Health Sciences, Kartal Dr. Lütfi Kırdar Training and Research Hospital, Istanbul, Turkey.
PMID:
34046582
PMCID:
PMC8140880
DOI:
10.46497/ArchRheumatol.2021.8228
No abstract available